Deborah White


  • Director, Cancer Program, Cancer
  • 4031 Citations
  • 26 h-Index
1987 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Professor White is the Director of the Cancer Program and Deputy Precision Medicine Theme Leader at the South Australian Health and Medical Research Institute (SAHMRI) in Adelaide. She is a NHMRC RD Wright Biomedical Research Fellow, a Beat Cancer Prinicpal Research Fellow and Senior Principal Research Fellow with SAHMRI. She is a Professor in Health and  Medical Sciences at the University of Adelaide and Health Sciences at Uni SA.


Prof White’s research focus is genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia (ALL) and Chronic Myeloid Leukaemia (CML) and she holds peer reviewed grants from: The William Lawrence and Blanche Hughes Foundation and the Leukemia Lymphoma Society (USA), the NHMRC, the Leukaemia Foundation Australia (LFA), Channel 7, Cancer Australia, Tour de Cure and the Cancer Council SA (CCSA). Professor White has presented more than 170 papers at scientific meetings, and authored more than 100 scientific publications as well as being an inventor on several international patents.


Professor White is the National Flagship Lead for the ALL Stream of Australian Genomics, and SA scientific lead for Zero Children’s Cancer She is an active member of the National Health & Medical Research Council (NHMRC) being a member of the NHMRC Academy, the Translational Research Program Advisory Committee, and the Women in Health Science (WiHS) Committee. She is a member of the Editorial Board for Cancer Letters.


In 2014 she was recognised as the Australian Society for Medical Research (ASMR) Leading Light for her Medical Research and in 2016 was awarded the University of Adelaide James McWha medal. In 2019 she was awarded a prestigious NHMRC Research Excellence Award.

Education/Academic qualification

Fellowship of the Royal College of Pathologists of Australia, Royal College of Pathologists of Australasia

PhD, University of Adelaide

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2019

Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib

Kok, C., Yeung, D., Lu, L., Watkins, D. B., Gray, T., Dang, Y., Saunders, V., Reynolds, J., White, D. & Hughes, T., 28 May 2019, In : Blood Advances. 3, 10, p. 1610-1621 12 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

Ross, D. M., Pagani, I., Irani, Y., Clarson, J., Gray, T., Dang, Y., McLean, J., Saunders, V., Carne, L., Reynolds, J., Ritchie, D. S., White, D., Branford, S., Hughes, T. & Yong, A., 1 Aug 2019, In : British Journal of Haematology. 186, 3, p. e56-e60

Research output: Contribution to journalLetter

7 Citations (Scopus)

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia

Pagani, I. S., Dang, P., Kommers, I. O., Goyne, J. M., Nicola, M., Saunders, V. A., Braley, J., White, D. L., Yeung, D. T., Branford, S., Hughes, T. P. & Ross, D. M., 30 Nov 2018, In : Haematologica. 103, 12, p. 2026-2032 7 p.

Research output: Contribution to journalArticle

Open Access
3 Citations (Scopus)

Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten

Nair, S. S., Luu, P. L., Qu, W., Maddugoda, M., Huschtscha, L., Reddel, R., Chenevix-Trench, G., Toso, M., Kench, J. G., Horvath, L. G., Hayes, V. M., Stricker, P. D., Hughes, T. P., White, D. L., Rasko, J. E. J., Wong, J. J. L. & Clark, S. J., 28 May 2018, In : Epigenetics and Chromatin. 11, 1, 24.

Research output: Contribution to journalArticle